1. |
Blair AB, Reames BN, Singh J, et al. Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution. J Surg Oncol, 2018, 118(1): 127-137.
|
2. |
Tseng WW, Seo HJ, Pollock RE, et al. Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma. J Surg Oncol, 2018, 117(1): 7-11.
|
3. |
Trans-Atlantic RPS Working Group. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol, 2015, 22(1): 256-263.
|
4. |
Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol, 2016, 17(7): 966-975.
|
5. |
Ng D, Swallow CJ. Decision-making for palliative versus curative intent treatment of retroperitoneal sarcoma (RPS). Chin Clin Oncol, 2018, 7(4): 40.
|
6. |
Baldini E. Retroperitoneal sarcoma: setting the stage for treatment strategies tailored to histologic subtype and other patient and tumor factors. Int J Radiat Oncol Biol Phys, 2017, 99(2): 292-295.
|
7. |
Tan MC, Brennan MF, Kuk D, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg, 2016, 263(3): 593-600.
|
8. |
Honoré C, Faron M, Mir O, et al. Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: the Gustave Roussy experience. J Surg Oncol, 2018, 118(8): 1318-1325.
|
9. |
Zaidi MY, Canter R, Cardona K. Post-operative surveillance in retroperitoneal soft tissue sarcoma: the importance of tumor histology in guiding strategy. J Surg Oncol, 2018, 117(1): 99-104.
|
10. |
Fairweather M, Wang J, Jo VY, et al. Incidence and adverse prognostic implications of histopathologic organ invasion in primary retroperitoneal sarcoma. J Am Coll Surg, 2017, 224(5): 876-883.
|
11. |
Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol, 2018, 117(1): 62-68.
|
12. |
Fairweather M, Gonzalez RJ, Strauss D, et al. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol, 2018, 117(1): 33-41.
|
13. |
van Houdt WJ, Zaidi S, Messiou C, et al. Treatment of retroperitoneal sarcoma: current standards and new developments. Curr Opin Oncol, 2017, 29(4): 260-267.
|
14. |
Raut CP, Callegaro D, Miceli R, et al. Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG. Clin Cancer Res, 2019, [Epub ahead of print].
|
15. |
Cananzi FCM, Ruspi L, Sicoli F, et al. Did outcomes improve in retroperitoneal sarcoma surgery? Surg Oncol, 2019, 28: 96-102.
|
16. |
Gyorki DE, Brennan MF. Management of recurrent retroperitoneal sarcoma. J Surg Oncol, 2014, 109(1): 53-59.
|
17. |
Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol, 2009, 27(1): 31-37.
|
18. |
吴德全. 复发性腹膜后脂肪肉瘤诊治分析. 中国实用外科杂志, 2014, 34(4): 336-338.
|
19. |
罗成华, 金黑鹰, 苗成利, 等. 腹膜后脂肪肉瘤诊断和治疗专家共识 (2016). 中国微创外科杂志, 2016, 16(12): 1057-1063.
|
20. |
Pisters PW. Resection of some-but not all-clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol, 2009, 27(1): 6-8.
|
21. |
Raut CP, Swallow CJ. Are radical compartmental resections for retroperitoneal sarcomas justified? Ann Surg Oncol, 2010, 17(6): 1481-1484.
|
22. |
MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: a report from the Trans-Atlantic RPS Working Group. Cancer, 2017, 123(11): 1971-1978.
|
23. |
Chiappa A, Bertani E, Pravettoni G, et al. Aggressive surgical approach for treatment of primary and recurrent retroperitoneal soft tissue sarcoma. Indian J Surg, 2018, 80(2): 154-162.
|
24. |
Crago AM. Extended surgical resection and histology in retroperitoneal sarcoma. Ann Surg Oncol, 2015, 22(5): 1401-1403.
|
25. |
MacNeill AJ, Fiore M. Surgical morbidity in retroperitoneal sarcoma resection. J Surg Oncol, 2018, 117(1): 56-61.
|
26. |
Keung EZ, Chiang YJ, Cormier JN, et al. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer, 2018, 124(23): 4495-4503.
|
27. |
罗成华, 苗成利. 腹膜后肿瘤的手术治疗策略与新趋势. 中国普外基础与临床杂志, 2016, 23(3): 257-259.
|
28. |
Maurice MJ, Yih JM, Ammori JB, et al. Predictors of surgical quality for retroperitoneal sarcoma: volume matters. J Surg Oncol, 2017, 116(6): 766-774.
|
29. |
Toulmonde M, Bonvalot S, Méeus P, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol, 2014, 25(3): 735-742.
|
30. |
Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol, 2010, 17(6): 1507-1514.
|
31. |
Fairweather M, Wang J, Jo VY, et al. Surgical management of primary retroperitoneal sarcomas: rationale for selective organ resection. Ann Surg Oncol, 2018, 25(1): 98-106.
|
32. |
Abdelfatah E, Guzzetta AA, Nagarajan N, et al. Long-term outcomes in treatment of retroperitoneal sarcomas: a 15 year single-institution evaluation of prognostic features. J Surg Oncol, 2016, 114(1): 56-64.
|
33. |
Anaya DA, Lahat G, Liu J, et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg, 2009, 249(1): 137-142.
|
34. |
Wilkinson KH, Ethun CG, Hembrook M, et al. Outcomes of elderly patients undergoing curative resection for retroperitoneal sarcomas: analysis from the US sarcoma collaborative. J Surg Res, 2019, 233: 154-162.
|
35. |
Sourrouille I, Macovei R, Faron M, et al. Long-term outcome after surgery for a localized retroperitoneal soft tissue sarcoma in elderly patients: results from a retrospective, single-center study. Ann Surg Oncol, 2018, 25(8): 2201-2208.
|
36. |
Almond LM, Gronchi A, Strauss D, et al. Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. Eur J Surg Oncol, 2018, 44(5): 571-579.
|
37. |
Roeder F, Alldinger I, Uhl M, et al. Intraoperative electron radiation therapy in retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys, 2018, 100(2): 516-527.
|
38. |
Constantinidou A, Jones RL. Systemic therapy in retroperitoneal sarcoma management. J Surg Oncol, 2018, 117(1): 87-92.
|
39. |
Haas RL, Baldini EH, Chung PW, et al. Radiation therapy in retroperitoneal sarcoma management. J Surg Oncol, 2018, 117(1): 93-98.
|
40. |
Datta J, Ecker BL, Neuwirth MG, et al. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: evidence from a nationwide clinical oncology database and review of the literature. Surg Oncol, 2017, 26(2): 117-124.
|